J. Erdmann

Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.

H. Adelsberger, J. Grosskreutz, C. Lersch, 2002, Clinical colorectal cancer.

Phase II Trial of a 24-Hour Infusion of Gemcitabine in Previously Untreated Patients with Advanced Pancreatic Adenocarcinoma

C. Lersch, F. Eckel, R. Schmelz, 2003, Cancer investigation.

[Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].

H. Adelsberger, C. Lersch, F. Eckel, 2002, Deutsche medizinische Wochenschrift.

Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.

P. Teillac, P. Grise, P. Ballanger, 2004, European urology.

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study

H. Adelsberger, R. Schmid, F. Obermeier, 2006, Investigational New Drugs.

Noninvasive Power Doppler–Mediated Diagnosis of Catheter Leakage in a Totally Implanted Venous Access Port

A. Ungeheuer, K. Stock, C. Lersch, 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Linac radiosurgery in brain metastases.

R. Müller, O. Pastyr, W. Schlegel, 2001, Acta neurochirurgica. Supplement.

External radiotherapy of pituitary adenomas.

M. Wannenmacher, M. Flentje, M. Wannenmacher, 1995, International journal of radiation oncology, biology, physics.

Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.

C. Lersch, F. Eckel, V. Schusdziarra, 2004, Hepato-Gastroenterology.